Vita 34 AG (V3V):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vita 34 AG (V3V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3476
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vita 34 AG (Vita 34), formerly Vita 34 International AG, is an umbilical cord blood bank that collects, prepares, processes, deposits, and stores stem cells from umbilical cord blood. The company’s products comprise vitaplus, vitaplus25, vitaplus50, vitapluscordtissue, vitapluscordtissue25, and vitapluscordtissue50. Vita 34 conducts research on umbilical cord blood used in acquired hearing loss, early childhood brain damage, aplastic anemia, blood cancer, solid tumors, type 1 diabetes, and gene therapy for severe immune deficiency. The company also provides vitaplus donation, and preventive screening services. It has operations in the US, Austria, Switzerland and Spain. Vita 34 is headquartered in Leipzig, Germany.

Vita 34 AG (V3V) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vita 34 AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vita 34 AG, Medical Devices Deals, 2012 to YTD 2018 9
Vita 34 AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vita 34 AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Vita 34 to Acquire Assets from Vivocell Biosolutions for USD0.8 Million 11
Equity Offering 12
Vita 34 Raises USD5.4 Million in Rights Offering of Shares 12
Acquisition 13
VITA 34 Acquires 100% Stake in Seracell Pharma 13
Vita 34 Acquires 30% Stake in Bio Save 14
VITA 34 Acquires 75.24% Stake In Stellacure 15
Medivision Acquires 51% Stake In Stellacure From Cord Blood America 16
VITA 34 Acquires BioPlanta, Developer Of Active Herbal Ingredients 17
Vita 34 AG – Key Competitors 18
Vita 34 AG – Key Employees 19
Vita 34 AG – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 08, 2017: Vita 34 adjusts revenues and earnings targets for 2017 21
Feb 01, 2017: Vita 34 increased its turnover in 2016 by 14 per cent in comparison to the previous year 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Vita 34 AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vita 34 AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vita 34 AG, Deals By Therapy Area, 2012 to YTD 2018 8
Vita 34 AG, Medical Devices Deals, 2012 to YTD 2018 9
Vita 34 AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vita 34 to Acquire Assets from Vivocell Biosolutions for USD0.8 Million 11
Vita 34 Raises USD5.4 Million in Rights Offering of Shares 12
VITA 34 Acquires 100% Stake in Seracell Pharma 13
Vita 34 Acquires 30% Stake in Bio Save 14
VITA 34 Acquires 75.24% Stake In Stellacure 15
Medivision Acquires 51% Stake In Stellacure From Cord Blood America 16
VITA 34 Acquires BioPlanta, Developer Of Active Herbal Ingredients 17
Vita 34 AG, Key Competitors 18
Vita 34 AG, Key Employees 19
Vita 34 AG, Subsidiaries 20

List of Figures
Vita 34 AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vita 34 AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vita 34 AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Vita 34 AG (V3V):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suzlon Energy Ltd (SUZLON):電力:M&Aディール及び事業提携情報
    Summary Suzlon Energy Ltd (Suzlon) is a provider of renewable energy solutions. It offers total solutions package that covers the entire wind energy projects scope. The company provides complete turnkey solutions from design to lifecycle asset management. Suzlon also generates electricity; and sells …
  • GFI Informatique:企業の戦略・SWOT・財務分析
    GFI Informatique - Strategy, SWOT and Corporate Finance Report Summary GFI Informatique - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • RespireRx Pharmaceuticals Inc (RSPI):企業の財務・戦略的SWOT分析
    RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Breakthru Beverage Group, LLC:企業の戦略・SWOT・財務分析
    Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Korea Aerospace Industries Ltd:企業の戦略・SWOT・財務分析
    Korea Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Korea Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sony Financial Holdings Inc.:企業の戦略・SWOT・財務分析
    Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Chatham Lodging Trust:企業の戦略・SWOT・財務情報
    Chatham Lodging Trust - Strategy, SWOT and Corporate Finance Report Summary Chatham Lodging Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Solvay Specialty Polymers Italy SpA:企業の戦略的SWOT分析
    Solvay Specialty Polymers Italy SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • The TJX Companies, Inc. (TJX):企業の財務・戦略的SWOT分析
    The TJX Companies, Inc. (TJX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Advent Capital (Holdings) Ltd:企業の戦略・SWOT・財務情報
    Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Inchcape plc (INCH):企業の財務・戦略的SWOT分析
    Inchcape plc (INCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Agfa HealthCare NV-医療機器分野:企業M&A・提携分析
    Summary Agfa HealthCare NV (Agfa HealthCare) a subsidiary of Agfa-Gevaert NV is a healthcare technology company that develops, produces and distributes analog and digital imaging systems and information technology solutions. The company operates through diagnostic imaging, enterprise imaging, integr …
  • ITC Holdings Corp.:発電所・企業SWOT分析
    ITC Holdings Corp. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • Cyteir Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cyteir Therapeutics Inc (Cyteir Therapeutics) discovers, develops and commercializes synthetic lethal therapeutics for the treatment of cancer and autoimmune disease. It specializes in the development of small molecules that targets RAD51 to induce synthetic lethality in diseases with a gain …
  • Gran Tierra Energy Inc. (GTE)-石油・ガス分野:企業M&A・提携分析
    Summary Gran Tierra Energy Inc. (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia; and also owns …
  • Kuwait Oil Co:企業の戦略的SWOT分析
    Kuwait Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • GenMark Diagnostics Inc (GNMK):企業の財務・戦略的SWOT分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company offers products such as XT-8 systems and ePlex systems. It offers pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test, …
  • Emgesa SA ESP-エネルギー分野:企業M&A・提携分析
    Summary Emgesa SA ESP (Emgesa), a subsidiary of Enel, is an energy utility that generates and trades electricity. The company produces power from hydro, coal, and oil and gas; and procures energy from generator and trader agents in the wholesale market. It owns thermal stations: Cartagena and Martin …
  • Nostra Terra Oil and Gas Company Plc (NTOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Nostra Terra Oil and Gas Company Plc (NTOG) is an oil and gas company. The company explores, produces, and develops oil and gas properties across the US. It holds interest in operating and non-operating working interests in its projects located in Texas, New Mexico, Wyoming, Kansas, Colorado …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆